<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="178294">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00774059</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 08-1-024</org_study_id>
    <nct_id>NCT00774059</nct_id>
  </id_info>
  <brief_title>Evaluation of Safety and Performance of the Orbix Breast Lift System</brief_title>
  <official_title>Phase 1 Study to Evaluate the Safety and Performance of the Orbix Breast Lift System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is using a new breast lift system to complement a breast-lift operation.

      In general there will be recurrence of breast-ptosis after a correcting operation.

      With this device we want to minimize this recurrence and provide an &quot;internal bra&quot;.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">January 2011</completion_date>
  <primary_completion_date type="Anticipated">January 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Result after using the breast lift system,recurrence of ptosis.</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Breast Ptosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Breast lift system</intervention_name>
    <description>During a breast operation for ptosis a device is brought into the breast and attached to the ribs, to provide lifting of the breast</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1.Female subject between 30-50 years of age 2. Subject is referred for mastopexy(breast
        lifting)due to one of the following reasons:

          -  Breast ptosis grade I or II (minimal invasive)

          -  Breast ptosis grade I to IV (open procedure)

          -  pseudoptosis following breast reduction surgery 3. subject willing to participate as
             evidenced by signing the written informed consent 4. Minimal invasive: breast cup
             size &lt;C

        Exclusion Criteria:

          1. Pregnant or lactating women

          2. history of surgical procedures involving the ribs and rib cage

          3. Osteoporosis

          4. breast implants

          5. breast carcinoma

          6. auto-immune disease -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marjoes MP Schuckman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adi Cohen</last_name>
    <role>Study Director</role>
    <affiliation>Orbix medical</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adi Cohen</last_name>
    <phone>972-4-6818800/1</phone>
    <email>adi@haargaz.co.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marjoes MP Schuckman, MD</last_name>
    <phone>0433876543</phone>
    <email>mschuckman@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maastricht Univeristy Hospital</name>
      <address>
        <city>Maastricht</city>
        <zip>6020AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Rene RJ v. d. Hulst, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <lastchanged_date>October 15, 2008</lastchanged_date>
  <firstreceived_date>October 15, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Adi Cohen</name_title>
    <organization>Orbix Medical</organization>
  </responsible_party>
  <keyword>Breast ptosis, Breast lift</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
